Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70

International Journal of Cancer

Volumn 135, Issue 9, 2014, Pages 2118-2128

  Shevtsov, Maxim A ^a   Pozdnyakov, Alexander V ^b   Mikhrina, Anastasia L ^c   Yakovleva, Ludmila Y ^d   Nikolaev, Boris P ^d   Dobrodumov, Anatolii V ^e   Komarova, Elena Y ^a   Meshalkina, Darya A ^a   Ischenko, Alexander M ^d   Pitkin, Emil ^f   Guzhova, Irina V ^a   Margulis, Boris A ^a  

^a RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^b Department of Radiology City Clinical Oncology Dispenser ^*  (Russian Federation)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^d Institute for Highly Pure Biopreparations   (Russian Federation)

^e INSTITUTE OF MACROMOLECULAR COMPOUNDS   (Russian Federation)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antitumor immunity; brain tumor; glioblastoma; heat shock protein 70; immunotherapy

Indexed keywords

GAMMA INTERFERON; GRANZYME B; HEAT SHOCK PROTEIN 70;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; GLIOBLASTOMA; IMMUNOSTIMULATION; LIFESPAN; LYMPHOCYTIC INFILTRATION; MALE; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TUMOR VOLUME;

ANTITUMOR IMMUNITY; BRAIN TUMOR; GLIOBLASTOMA; HEAT SHOCK PROTEIN 70; IMMUNOTHERAPY;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GLIOBLASTOMA; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; INTERFERON-GAMMA; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; RATS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 84906274976     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28858     Document Type: Article

References (37)

1. Ohgaki H, Kleihues P,. Epidemiology and etiology of gliomas. Acta Neuropathol 2005; 109: 93-108.
2. Central Brain Tumor Registry of the United States analyses of the NPCR and SEER data, 2004-2007. http://www.cbtrus.org/factsheet/factsheet.html.
3. Chamberlain MC,. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert Rev Neurother 2010; 10: 1537-44.
4. Srivastava P,. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20: 395-425.
5. Chang CL, Tsai YC, He L, et al. Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70. Cancer Res 2007; 67: 10047-57.
6. Nishikawa M, Otsuki T, Ota A, et al. Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice. Mol Ther 2010; 18: 421-8.
7. Ito A, Matsuoka F, Honda H, et al. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother 2004; 53: 26-32.
8. Abkin SV, Pankratova KM, Komarova EY, et al. Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool. Cell Stress Chaperones 2013; 18: 391-6.
9. Gastpar R, Gross C, Rossbacher L, et al. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol 2004; 172: 972-80.
10. Schilling D, Gehrmann M, Steinem C, et al. Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells. FASEB J 2009; 23: 2467-77.
11. Sherman M, Multhoff G,. Heat shock proteins in cancer. Ann N Y Acad Sci 2007; 1113: 192-201.
12. Murshid A, Theriault J, Gong J, et al. Investigating receptors for extracellular heat shock proteins. Methods Mol Biol 2011; 787: 289-302.
13. Asea A,. Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr Immunol Rev 2006; 2: 209-15.
14. Calderwood SK, Ciocca DR,. Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperthermia 2008; 24: 31-9.
15. Guzhova IV, Lazarev VF, Kaznacheeva AV, et al. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of Huntington disease. Hum Mol Genet 2011; 20: 3953-63.
16. Guzhova IV, Margulis BA, Kaminskaya EV,. Antibody against p58 surface antigen of RA-2 rat rhabdomyosarcoma cells inhibits their metastatic activity. Int J Cancer 1992; 52: 892-5.
17. Spaeth N, Wyss MT, Pahnke J, et al. Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19). Nucl Med Biol 2006; 33: 661-6.
18. Tanriover N, Ulu MO, Sanus GZ, et al. The effects of systemic and intratumoral interleukin-12 treatment in C6 rat glioma model. Neurol Res 2008; 30: 511-17.
19. Orozco-Morales M, Sanchez-Garcia FJ, Guevara-Salazar P, et al. Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin. J Cancer Res Clin Oncol 2012; 138: 23-33.
20. Dressel R, Grzeszik C, Kreiss M, et al. Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes. Cancer Res 2003; 63: 8212-20.
21. Shevtsov MA, Yakovleva LY, Nikolaev BP, et al. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma. Neuro Oncol 2014; 16: 38-49.
22. Mambula SS, Stevenson MA, Ogawa K, et al. Mechanisms for Hsp70 secretion: crossing membranes without a leader. Methods 2007; 43: 168-75.
23. Geng H, Zhang GM, Xiao H, et al. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progressionof pulmonary metastatic melanoma. Int J Cancer 2006; 118: 2657-64.
24. Multhoff G,. Activation of natural killer cells by heat shock protein 70. 2002. Int J Hyperthermia 2009; 25: 169-75.
25. Chu RS, Targoni OS, Krieg AM, et al. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997; 186: 1623-31.
26. Alizadeh D, Zhang L, Brown CE, et al. Induction of anti-glioma NK cell response following multiple low-dose intracerebral CpG therapy. Clin Cancer Res 2010; 16: 3399-408.
27. Roda JM, Parihar R, Carson WE, III,. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. J Immunol 2005; 175: 1619-27.
28. Yang I, Huh NG, Smith ZA, et al. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am 2010; 21: 181-6.
29. Lazovic J, Jensen MC, Ferkassian E, et al. Imaging immune response in vivo: cytolytic action of genetically altered T-cells directed to glioblastoma multiforme. Clin Cancer Res 2008; 14: 3832-9.
30. Galons JP, Altbach MI, Paine-Murrieta GD, et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999; 1: 113-17.
31. Chenevert TL, McKeever PE, Ross BD,. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997; 3: 1457-66.
32. Gao B, Tsan MF,. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 2003; 278: 174-9.
33. Zheng H, Nagaraja GM, Kaur P, et al. Chaperokine function of recombinant Hsp72 produced in insect cells using a baculovirus expression system is retained. J Biol Chem 2010; 285: 349-56.
34. Henderson B, Calderwood SK, Coates ARM, et al. Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants. Cell Stress Chaperones 2010; 15: 123-41.
35. Weng D, Calderwood SK, Gong J,. Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells. Methods Mol Biol 2011; 787: 255-65.
36. Feng H, Zeng Y, Graner MW, et al. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 2003; 101: 245-51.
37. Massa C, Guiducci C, Arioli I, et al. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res 2004; 64: 1502-8.